#Hunter syndrome

FDA Approval of Denali Therapeutics Drug Enhances Rare Disease Treatment Landscape

The FDA's recent approval of Denali Therapeutics' drug for Hunter syndrome signifies a pivotal change in regulatory attitudes towards rare disease therapies.